PRAKTYKA LEKARSKA EWA KRZYŻAGÓRSKA
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At PRAKTYKA LEKARSKA EWA KRZYŻAGÓRSKA in Poznan, clinical research in cardiovascular diseases focuses on conditions such as atherosclerosis, atherosclerotic cardiovascular disease, and broader cardiovascular disease risk. These studies are designed to assess whether new approaches can better reduce major heart and blood vessel complications and improve long-term outcomes.
- Evaluating therapies aimed at lowering the risk of major cardiovascular events
- Studying treatment options for people with atherosclerotic cardiovascular disease and excess weight
- Testing whether new medicines can improve cardiovascular safety and protection
The site is contributing to research that looks beyond symptom control, with a strong emphasis on preventing serious outcomes such as heart attack, stroke, and cardiovascular death.
Nervous System Diseases
Research in nervous system diseases at this site includes work on chronic pain due to diabetic peripheral neuropathy, a condition that can significantly affect daily life in people with diabetes. The trial activity in this area is centered on finding better ways to relieve pain and improve comfort for patients living with nerve-related complications.
- Testing a new treatment approach for diabetic nerve pain
- Exploring options to improve symptom relief in peripheral neuropathy
- Supporting research on pain management in diabetes-related nerve disease
This work highlights a practical clinical focus on easing persistent pain and improving quality of life for patients affected by diabetic neuropathy.
Nutritional and Metabolic Diseases
The nutritional and metabolic diseases portfolio at PRAKTYKA LEKARSKA EWA KRZYŻAGÓRSKA includes studies in obesity, overweight, type 2 diabetes mellitus, hypertriglyceridemia, and mixed dyslipidemia. These trials are aimed at improving weight management, metabolic control, and lipid levels, while also examining how these conditions affect overall cardiovascular risk.
- Evaluating treatments for weight reduction and metabolic health
- Studying ways to improve blood sugar control in type 2 diabetes
- Assessing therapies for high triglycerides and mixed lipid disorders
The research reflects a broad interest in common metabolic conditions that often overlap, with the goal of finding more effective and safer treatment options for patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in PRAKTYKA LEKARSKA EWA KRZYŻAGÓRSKA
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial | Metsera Inc. | Phase III | Not Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azd5004 | 1 | Unknown | 2025-02-24 | 2025-02-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.